<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CORTISONE ACETATE</span><br/>(kor'ti-sone)<br/><span class="topboxtradename">Cortistan, </span><span class="topboxtradename">Cortone<br/></span><b>Classifications:</b> <span class="classification">hormones and synthetic substitutes</span>; <span class="classification"> synthetic adrenal corticosteroid</span>; <span class="classification">glucocorticoid</span><br/><b>Prototype: </b>Prednisone<br/><b>Pregnancy Category: </b>D<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>5 mg, 10 mg, 25 mg tablets; 50 mg/mL injection</p>
<h1><a name="action">Actions</a></h1>
<p>Short-acting synthetic steroid with prominent glucocorticoid activity and mineralocorticoid effects approximately equal to
         those of prednisone (cortisol). Because therapeutic activity of cortisone results from its conversion in body to cortisol,
         its effects simulate those of hydrocortisone. Metabolic effects include promotion of protein, carbohydrate, and fat metabolism
         and interference with linear growth in children.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Mineralocorticoid actions include promotion of sodium retention and potassium excretion. May foster development of osteoporosis.
         Has antiinflammatory and immunosuppressive actions.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Replacement therapy for primary or secondary adrenocortical insufficiency and inflammatory and allergic disorders.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to glucocorticoids; psychoses; viral or bacterial diseases of skin; Cushing's syndrome, immunologic procedures;
         pregnancy (category D), lactation. Safe use in children not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Diabetes mellitus; hypertension, CHF; active or arrested tuberculosis; active or latent peptic ulcer.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Replacement or Inflammatory Disorders</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO/IM</span> 20300 mg/d in 1 or more divided doses, try to reduce periodically by 1025 mg/d to lowest effective dose<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 2.510 mg/kg/d divided q68h; <span class="rdroute">IM</span> 15 mg/kg/d divided q1224h<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Administer cortisone (usually in a.m.) with food or fluid of patient's choice to reduce gastric irritation.</li>
<li>Sodium chloride and a mineralocorticoid are usually given with cortisone as part of replacement therapy.</li>
</ul><span class="adminroutetype">Intramuscular</span><br/><ul>
<li>Parenteral cortisone is a suspension (25 mg/mL) and therefore should not be used IV. Shake bottle well before withdrawing
            dose.
         </li>
<li>Give deep IM into a large muscle.</li>
<li>Drug must be gradually tapered rather than withdrawn abruptly.</li>
<li>Store at 15°30° C (59°86° F) in tightly closed container unless otherwise directed by manufacturer.
            Protect from heat and freezing.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> CV:</span> CHF, hypertension, <span class="speceff-common">edema</span>. <span class="typehead"> GI:</span>
<span class="speceff-common">Nausea,</span> peptic ulcer, pancreatitis. <span class="typehead"> Endocrine:</span> Hyperglycemia. <span class="typehead">Hematologic:</span> Thrombocytopenia. <span class="typehead">Musculoskeletal:</span>
<span class="speceff-common">Compression fracture,</span> osteoporosis, muscle weakness.  <span class="typehead">CNS:</span> Euphoria, insomnia, vertigo, nystagmus. <span class="typehead">Skin:</span> Impaired wound healing, petechiae, ecchymosis, acne. <span class="typehead">Special Senses:</span>
<span class="speceff-common">Cataracts,</span> glaucoma, blurred vision. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<span class="classification">barbiturates</span>, <b>phenytoin,</b>
<b>rifampin</b> decrease effects of cortisone. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> Rapid PO; 2448 h IM. <span class="typehead">Peak:</span> 2 h PO; 2448 h IM. <span class="typehead">Duration:</span> 1.251.5 d. <span class="typehead">Distribution:</span> Concentrated in many tissues; crosses placenta; distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead"> Elimination:</span>  Excreted in urine. <span class="typehead">Half-Life:</span> 0.5 h; HPA suppression: 812 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for S&amp;S of Cushing's syndrome (see Appendix F), especially in patients on long-term therapy.</li>
<li>Lab tests: Periodic blood glucose and CBC with platelet count.</li>
<li>Cortisone may mask some signs of infection, and new infections may appear.</li>
<li>Be alert to clinical indications of infection: malaise, anorexia, depression, and evidence of delayed healing. (Classic signs
            of inflammation are suppressed by cortisone.)
         </li>
<li>Report ecchymotic areas, unexplained bleeding, and easy bruising.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Take drug exactly as prescribed. Do not alter dose intervals or stop therapy abruptly.</li>
<li>Monitor weight and report a steady gain especially if it is accompanied by signs of fluid retention (e.g., edema of ankles
            or hands).
         </li>
<li>Report changes in visual acuity, including blurring, promptly.</li>
<li>Inform physician or dentist that cortisone is being taken. Carry identification card or jewelry that states drug being taken
            and physician's name.
         </li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>